Please login to the form below

Microbiome

This page shows the latest Microbiome news and features for those working in and with pharma, biotech and healthcare.

Seres’ microbiome-based therapy hits the mark in phase 3

Drug reduced C.difficile infection recurrence. Seres Therapeutics has reported positive topline data from a phase 3 trail of its microbiome therapy SER-109 for recurrent C.difficile infections. ... SER-109 is an oral, biologically-derived microbiome

Latest news

Bayer bulks up in women’s health again with non-hormonal contraceptive deal

The Evotec and Daré deals sandwiched two other agreements signed in the last few days, including a partnership with Azitra to develop skin microbiome-based treatments for eczema, and another with
Finch Therapeutics bags $53m for microbiome therapies

Finch’s pipeline includes CP101, an oral capsule that contains a diverse community of microbiota to restore a balanced microbiome. ... Prior studies have suggested the link between the two is a disrupted microbiome.
AZ signs $20m deal with Seres for microbiome project

of Seres’ microbiome candidates – SER-401 – tested in combination with AZ’s cancer therapies including its PD-L1 checkpoint inhibitor Imfinzi (durvalumab). ... One of the targets of the AZ-backed project will be to see if the microbiome can serve
Finch’s microbiota drug for C. diff gets FDA breakthrough status

diff – along with other beneficial bacteria in the gut – they can be used to restore the balance of the bacterial colonies or ‘microbiome’ that naturally populate our bodies. ... Takeda bought into the programme in 2017, and is also partnering
Ex-Pharmacyclics CEO invests $25m in Summit

damaging to the normal microbiome of the gastrointestinal tract. ... Preserving the microbiome makes it less likely that the pathogen can re-establish itself once treatment finishes, it suggests.

More from news
Approximately 7 fully matching, plus 10 partially matching documents found.

Latest Intelligence

Gut instincts lead Takeda to GI pipeline success

Takeda’s strategy is to develop GI products that address the highest unmet needs, which includes projects across three novel platforms – gene therapy, microbiome and cell therapy.
A snapshot of Microbiotica

How is Microbiotica advancing life sciences with its technology? Microbiotica is a leading expert in the microbiome and is using its technology to identify the good and bad microbiomes in patients. ... There is also a $534m collaboration with Roche’s
Pharma’s coral reef

If you need another example, look in the mirror and consider that a large part of the creature facing you is made of other organisms, such as those in your microbiome.
Deal Watch November 2016

immuno-oncology collaboration based on Enterome's microbiome technology.
Building the Future

The human microbiome is an example of this but a coral reef is a better one.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

Former Genzyme group vice president joins Vedanta Biosciences

His experience and leadership in pioneering new drug modalities will be invaluable as we advance our pipeline of microbiome-modulating therapies.”. ... Dr Roberts said: “Microbiome modulation is among the most exciting and rapidly evolving fields in
Vedanta Biosciences appoints two new heads

Vedanta is advancing a pipeline of product candidates designed to treat autoimmune, inflammatory and infectious diseases using technology that mines the human microbiome for potent pharmaceutical products.
Ritter Pharmaceuticals appoints new CMO

Ritter is currently developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. ... microbiome. “I believe my experience in product development coupled with my research capabilities will be a great

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

Mastering the precision medicine opportunity

This data will come from a patient’s genetics, electronic health records, microbiome, diet, lifestyle, and will be the driving force behind improved outcomes.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Lead Copywriter: Competitive

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Account Director: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Healthcare Senior Account Manager: Competitive

Account Director – Creative Healthcare Communications: Competative

Medical Editor: Competitive

PMHub

Add my company

Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

The search for effective drug treatments for COVID-19: PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....